Author:
Jin Xin,Ma Xiaoting,Zhao Dong,Yang Lin,Ma Nan
Reference55 articles.
1. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma;J. Hepatol.,2018
2. Surgery for recurrent hepatocellular carcinoma: achieving long-term survival;Yoh;Ann. Surg.,2021
3. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches;Sapisochin;Nat. Rev. Gastroenterol. Hepatol.,2017
4. IMbrave150: exploratory efficacy and safety results in patients with hepatocellular carcinoma without macrovascular invasion or extrahepatic spread treated with Atezolizumab + Bevacizumab or Sorafenib;Gastroenterol. Hepatol. (N. Y.),2021
5. Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Clinical Trial;Yau;JAMA Oncol.,2020